|
|
|
|
| LEADER |
03476nam a2200865Ia 4500 |
| 001 |
10-3389-fpsyt-2022-754938 |
| 008 |
220420s2022 CNT 000 0 und d |
| 020 |
|
|
|a 16640640 (ISSN)
|
| 245 |
1 |
0 |
|a Psychotic Symptoms as the Initial Presentation of a Long-Lasting Misdiagnosed Anti-GAD65 Autoimmune Encephalitis: An Emblematic Case and Literature Review
|
| 260 |
|
0 |
|b Frontiers Media S.A.
|c 2022
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3389/fpsyt.2022.754938
|
| 520 |
3 |
|
|a Objective: To present a long-lasting misdiagnosed case of anti-GAD65 autoimmune encephalitis (AE) and promote the early identification of reversible psychotic symptoms in AE. Methods: The case report was generated through detailed assessment of clinical characteristics, cerebral magnetic resonance images, and laboratory results. Meanwhile, a literatures review related to the topic was conducted. Results: Psychotic symptoms could be presented in the early stage of anti-GAD65 autoimmune encephalitis. Even though there exists a transdisciplinary gap that hinder the timely recognition of early psychiatric symptoms as components of organic disease, a few strategies could be introduced to enable the earlier recognition and appropriate treatment. Conclusions: Our report intends to raise awareness to promote the early identification of immune-mediated “symptomatic” forms of psychosis. Copyright © 2022 Wang, Gong, Kong, Cai, Huang, Zheng, Lin, Li and Zhang.
|
| 650 |
0 |
4 |
|a adult
|
| 650 |
0 |
4 |
|a antibody blood level
|
| 650 |
0 |
4 |
|a antibody titer
|
| 650 |
0 |
4 |
|a Article
|
| 650 |
0 |
4 |
|a auditory hallucination
|
| 650 |
0 |
4 |
|a autoantibodies
|
| 650 |
0 |
4 |
|a autoantibody
|
| 650 |
0 |
4 |
|a autoimmune
|
| 650 |
0 |
4 |
|a autoimmune encephalitis
|
| 650 |
0 |
4 |
|a autoimmune hepatitis
|
| 650 |
0 |
4 |
|a autoimmune hepatitis
|
| 650 |
0 |
4 |
|a awareness
|
| 650 |
0 |
4 |
|a behavior disorder
|
| 650 |
0 |
4 |
|a carbamazepine
|
| 650 |
0 |
4 |
|a case report
|
| 650 |
0 |
4 |
|a Chinese
|
| 650 |
0 |
4 |
|a choline
|
| 650 |
0 |
4 |
|a clinical article
|
| 650 |
0 |
4 |
|a clinical feature
|
| 650 |
0 |
4 |
|a contrast medium
|
| 650 |
0 |
4 |
|a creatine
|
| 650 |
0 |
4 |
|a cyclophosphamide
|
| 650 |
0 |
4 |
|a diagnostic error
|
| 650 |
0 |
4 |
|a early diagnosis
|
| 650 |
0 |
4 |
|a electroencephalogram
|
| 650 |
0 |
4 |
|a encephalitis
|
| 650 |
0 |
4 |
|a encephalitis
|
| 650 |
0 |
4 |
|a epilepsy
|
| 650 |
0 |
4 |
|a epileptic discharge
|
| 650 |
0 |
4 |
|a female
|
| 650 |
0 |
4 |
|a fluorodeoxyglucose f 18
|
| 650 |
0 |
4 |
|a GAD65
|
| 650 |
0 |
4 |
|a glutamate decarboxylase 65 antibody
|
| 650 |
0 |
4 |
|a human
|
| 650 |
0 |
4 |
|a immunoglobulin
|
| 650 |
0 |
4 |
|a insomnia
|
| 650 |
0 |
4 |
|a laboratory test
|
| 650 |
0 |
4 |
|a methylprednisolone
|
| 650 |
0 |
4 |
|a multiple cycle treatment
|
| 650 |
0 |
4 |
|a nuclear magnetic resonance imaging
|
| 650 |
0 |
4 |
|a olanzapine
|
| 650 |
0 |
4 |
|a paranoia
|
| 650 |
0 |
4 |
|a positron emission tomography-computed tomography
|
| 650 |
0 |
4 |
|a prednisolone
|
| 650 |
0 |
4 |
|a proton nuclear magnetic resonance
|
| 650 |
0 |
4 |
|a psychosis
|
| 650 |
0 |
4 |
|a psychosis
|
| 650 |
0 |
4 |
|a risperidone
|
| 650 |
0 |
4 |
|a seizure (medical records)
|
| 650 |
0 |
4 |
|a symptom
|
| 650 |
0 |
4 |
|a tonic clonic seizure
|
| 650 |
0 |
4 |
|a topiramate
|
| 650 |
0 |
4 |
|a valproic acid
|
| 700 |
1 |
0 |
|a Cai, D.
|e author
|
| 700 |
1 |
0 |
|a Gong, S.
|e author
|
| 700 |
1 |
0 |
|a Huang, B.
|e author
|
| 700 |
1 |
0 |
|a Kong, F.
|e author
|
| 700 |
1 |
0 |
|a Li, J.
|e author
|
| 700 |
1 |
0 |
|a Lin, S.
|e author
|
| 700 |
1 |
0 |
|a Wang, J.
|e author
|
| 700 |
1 |
0 |
|a Zhang, T.
|e author
|
| 700 |
1 |
0 |
|a Zheng, H.
|e author
|
| 773 |
|
|
|t Frontiers in Psychiatry
|
